On June 13, 2025, at the EAACI Congress in Glasgow, Peter Schmid-Grendelmeier was honored with the EAACI Clinical Fellow Award 2025. He is the first Dermatologist to receive this prestigious recognition.
We are proud to have Peter Schmid-Grendelmeier as part of our CK-CARE team and to benefit from his outstanding scientific work and extensive expertise. We warmly congratulate him on this well-deserved award!
Atopic Dermatitis and Cardiovascular Disease – a deeper connection?
As part of our ongoing commitment to advancing the understanding of chronic inflammatory diseases, we at CK-CARE are proud to share the results of a newly published study in *Allergy* from our multicenter ProRaD research initiative.
Read the full publication: https://doi.org/10.1111/all.16588
The 20th CK-CARE Team Meeting took place on 24 and 25 February 2025 under the motto ‘Embracing the concept of data analysis to further personalised patient care’. The aim of the meeting was to develop innovative ideas and prepare a draft publication for the CK-CARE Scientific Board based on the data from the CK-CARE registry and biobank. The event began with an informative presentation of the data from the CK-CARE repository and the biobank, which provided the framework for intensive group work. The participants were divided into four teams: Team 1, 2 and 3 chose the topic according to their personal interest based on the available data from the CKC repository and the biobank, while team 4 focused on science communication for the NIA app. The day was rounded off with a guided tour of the historic Fuggerei in Augsburg followed by a tapas dinner at the Tafeldecker restaurant, which provided space for lively discussions. On Tuesday, each group presented their idea in a 3-minute ‘Scientific Paper Pitch’ to the critical members of the ‘CK-CARE Scientific Board-lion’s den’.
(Copyright Image: Samuel Tschaffon, UK Augsburg)
The 4th Davos Declaration: A Milestone for Atopic Dermatitis Patient Care
During the last Global Allergy Forum (GAF) key opinion leaders from science, medicine and industry met in Davos to discuss the current state of the art of patient care in atopic dermatitis (AD) and proposed new strategies for its improvement. The thinktank addressed the high prevalence of AD and strategized methods to advance research, diagnostics, management and prevention. The findings are now published as «Navigating the Evolving Landscape of Atopic Dermatitis: Challenges and Future Opportunities: the 4th Davos Declaration».
CK-CARE’s work has global resonance and, thanks to this strong position, significant projects in clinical allergy research were again launched or catalysed in the reporting year. CK-CARE’s working methods were sharpened in terms of medical translation and a strengthening of research capacities on the medical campus in Davos was defined in order to increase CK-CARE’s performance.
CK-CARE’s work now has global resonance and, thanks to this strong position, significant projects in clinical allergy research were again launched or catalysed in the reporting year. CK-CARE’s working methods were sharpened in terms of medical translation and a strengthening of research capacities on the medical campus in Davos was defined in order to increase CK-CARE’s performance.
“Entrepreneurial success should go hand in hand with the promotion of the common good. The Kühne Foundation fulfills this task. With a variety of programs and projects, the founder and the Kühne Foundation also assume their socio-political responsibility.”
The activities were significantly expanded, particularly in the area of logistics. In addition, the new focus area of climate action was established, and the first projects were launched.
Prof. Dr. h.c. Klaus-Michael Kühne
CK-CARE AG
Herman-Burchard-Strasse 12
CH-7265 Davos Wolfgang
Copyright © 2024 – CK-CARE | Website by PR24 GmbH
